Masato Abe

1.1k total citations
58 papers, 782 citations indexed

About

Masato Abe is a scholar working on Genetics, Neurology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Masato Abe has authored 58 papers receiving a total of 782 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Genetics, 18 papers in Neurology and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Masato Abe's work include Glioma Diagnosis and Treatment (27 papers), Meningioma and schwannoma management (7 papers) and Neuroblastoma Research and Treatments (6 papers). Masato Abe is often cited by papers focused on Glioma Diagnosis and Treatment (27 papers), Meningioma and schwannoma management (7 papers) and Neuroblastoma Research and Treatments (6 papers). Masato Abe collaborates with scholars based in Japan, United States and Sudan. Masato Abe's co-authors include Yuichi Hirose, Shigeo Ohba, Mitsuhiro Hasegawa, Seiji Yamada, Makoto Kuroda, Koji Kawakami, Raj K. Puri, Satoru Takahashi, Mariko Kawakami and Kazuhiro Murayama and has published in prestigious journals such as Journal of the American Chemical Society, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Masato Abe

55 papers receiving 764 citations

Peers

Masato Abe
Jonathan Serrano United States
Mario Löhr Germany
Lewis Hou United States
Haisong Liu United States
Victor C. K. Tse United States
J Piepmeier United States
Jonathan Serrano United States
Masato Abe
Citations per year, relative to Masato Abe Masato Abe (= 1×) peers Jonathan Serrano

Countries citing papers authored by Masato Abe

Since Specialization
Citations

This map shows the geographic impact of Masato Abe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masato Abe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masato Abe more than expected).

Fields of papers citing papers by Masato Abe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masato Abe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masato Abe. The network helps show where Masato Abe may publish in the future.

Co-authorship network of co-authors of Masato Abe

This figure shows the co-authorship network connecting the top 25 collaborators of Masato Abe. A scholar is included among the top collaborators of Masato Abe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masato Abe. Masato Abe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ohba, Shigeo, Eiji Fujiwara, Kazuhiro Murayama, et al.. (2025). Factors involved in maintaining Karnofsky Performance Status (≥ 50%) in glioblastoma, IDH-wildtype patients treated with temozolomide and radiotherapy. Scientific Reports. 15(1). 1750–1750. 1 indexed citations
2.
Sakai, Yasuhiro, et al.. (2023). Administration of spermidine attenuates concanavalin A-induced liver injury. Biochemical and Biophysical Research Communications. 648. 44–49. 3 indexed citations
3.
Ohba, Shigeo, Kazuhiro Murayama, Masao Yui, et al.. (2023). Three-Dimensional Amide Proton Transfer-Weighted Imaging for Differentiating between Glioblastoma, IDH-Wildtype and Primary Central Nervous System Lymphoma. Cancers. 15(3). 952–952. 2 indexed citations
5.
Murayama, Kazuhiro, Shigeo Ohba, Hikaru Sasaki, et al.. (2021). Association of preoperative seizures with tumor metabolites quantified by magnetic resonance spectroscopy in gliomas. Scientific Reports. 11(1). 7927–7927. 4 indexed citations
6.
Ohba, Shigeo, et al.. (2020). Correlation between IDH, ATRX, and TERT promoter mutations in glioma. Brain Tumor Pathology. 37(2). 33–40. 49 indexed citations
7.
Ohba, Shigeo, Seiji Yamada, Hikaru Sasaki, et al.. (2019). Clinical, histopathological, and molecular analyses of IDH-wild-type WHO grade II–III gliomas to establish genetic predictors of poor prognosis. Brain Tumor Pathology. 36(4). 135–143. 14 indexed citations
8.
Ohba, Shigeo, Yasuhiro Yamada, Kazuhiro Murayama, et al.. (2019). c-Met Expression Is a Useful Marker for Prognosis Prediction in IDH-Mutant Lower-Grade Gliomas and IDH-Wildtype Glioblastomas. World Neurosurgery. 126. e1042–e1049. 9 indexed citations
9.
Ohba, Shigeo, Kazuhiro Murayama, Masato Abe, Mitsuhiro Hasegawa, & Yuichi Hirose. (2019). Magnetic Resonance Imaging and Proton Magnetic Resonance Spectroscopy for Differentiating Between Enhanced Gliomas and Malignant Lymphomas. World Neurosurgery. 127. e779–e787. 6 indexed citations
10.
Murayama, Kazuhiro, et al.. (2017). Novel Application of Time-Spatial Labeling Inversion Pulse Magnetic Resonance Imaging for Diagnosis of External Hydrocephalus. World Neurosurgery. 109. 197–201. 2 indexed citations
11.
Murayama, Kazuhiro, Hikaru Sasaki, Yuya Nishiyama, et al.. (2016). Prediction of genetic subgroups in adult supra tentorial gliomas by pre- and intraoperative parameters. Journal of Neuro-Oncology. 131(2). 403–412. 24 indexed citations
12.
Mitsuya, Koichi, Yoko Nakasu, Yoshitaka Narita, et al.. (2016). “Comet tail sign”: A pitfall of post-gadolinium magnetic resonance imaging findings for metastatic brain tumors. Journal of Neuro-Oncology. 127(3). 589–595. 5 indexed citations
13.
Li, Xiuli, Kazuhiro Murayama, Ayumi Watanabe, Masato Abe, & Hiroshi Toyama. (2016). Primary Intracranial Choriocarcinoma Located in the Suprasellar Region. PubMed. 10(1). 80–84.
14.
Hirose, Yuichi, Hikaru Sasaki, Masato Abe, et al.. (2013). Subgrouping of gliomas on the basis of genetic profiles. Brain Tumor Pathology. 30(4). 203–208. 25 indexed citations
15.
Hirose, Yuichi, Hikaru Sasaki, Tomoru Miwa, et al.. (2011). Whole Genome Analysis From Microdissected Tissue Revealed Adult Supratentorial Grade II-III Gliomas Are Divided Into Clinically Relevant Subgroups by Genetic Profile. Neurosurgery. 69(2). 376–390. 16 indexed citations
16.
Komiyama, Shinichi, Eiji Nishio, Y. Torii, et al.. (2010). A case of primary uterine cervical neuroendocrine tumor with meningeal carcinomatosis confirmed by diagnostic imaging and autopsy. International Journal of Clinical Oncology. 16(5). 581–586. 13 indexed citations
17.
Imai, Hiroshi, Kazuyuki Shimada, Satoko Shimada, et al.. (2009). Comparative clinicopathological study of primary CNS diffuse large B-cell lymphoma and intravascular large B-cell lymphoma. Pathology International. 59(7). 431–437. 17 indexed citations
18.
Urano, Makoto, Masato Abe, Yoshimune Horibe, et al.. (2002). Sclerosing Mucoepidermoid Carcinoma with Eosinophilia of the Salivary Glands. Pathology - Research and Practice. 198(4). 305–310. 29 indexed citations
19.
Abe, Masato, Tsukasa Kawase, Makoto Urano, et al.. (2000). Analyses of proliferative potential in schwannomas. Brain Tumor Pathology. 17(1). 35–40. 15 indexed citations
20.
Kuroda, Makoto, Makoto Urano, Masato Abe, et al.. (2000). Primary primitive neuroectodermal tumor of the kidney. Pathology International. 50(12). 967–972. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026